R. Ohkubo

发表

Spinocerebellar ataxia 36 accompanied by cervical dystonia

H. Mochizuki, M. Nakazato, R. Hirano, 2015, Journal of the Neurological Sciences.

Chimeric Peptide Species Contribute to Divergent Dipeptide Repeat Pathology in c9ALS/FTD and SCA36

Chadwick M. Hales, L. Petrucelli, D. Dickson, 2020, Neuron.

Familial facioscapulohumeral muscular dystrophy: phenotypic diversity and genetic abnormality

M. Nakagawa, Y. Isashiki, M. Osame, 1996, Acta neurologica Scandinavica.

Type II muscle fibers are stained by anti-Fas antibody

M. Nakagawa, M. Osame, I. Higuchi, 1995, Journal of the Neurological Sciences.

Characteristic expression of cell adhesion molecules in adhalin deficiency

K. Arimura, M. Nakagawa, M. Osame, 1996, Journal of the Neurological Sciences.

Expression of the heparin-binding growth factor midkine in the cerebrospinal fluid of patients with neurological disorders.

M. Goto, F. Matsuda, T. Muramatsu, 2008, Internal medicine.

Detection of HTLV‐I provirus by in situ polymerase chain reaction in mononuclear inflammatory cells in skeletal muscle of viral carriers with polymyositis

K. Arimura, M. Nakagawa, S. Izumo, 1995, Muscle & nerve.

Early clinical signs and imaging findings in Gerstmann–Sträussler–Scheinker syndrome (Pro102Leu)

K. Arimura, R. Hirano, H. Takashima, 2006, Neurology.

Mutations in MME cause an autosomal‐recessive Charcot–Marie–Tooth disease type 2

S. Tsuji, J. Kira, S. Morishita, 2016, Annals of neurology.

Cerebrovascular disorders and genetic polymorphisms: mitochondrial DNA5178C is predominant in cerebrovascular disorders

S. Akiba, K. Arimura, M. Nakagawa, 2002, Journal of the Neurological Sciences.

Usefulness of transcutaneous Doppler jugular venous echo to predict pulmonary hypertension in COPD patients.

Y. Nakamura, M. Osame, W. Matsuyama, 2001, The European respiratory journal.

Familial skeletal myopathy with atrioventricular block.

M. Nakagawa, M. Osame, I. Higuchi, 1999, Internal medicine.

Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy

M. Katsuno, Y. Yamano, T. Tokashiki, 2024, Journal of neurology.